• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

加沙地带重型β地中海贫血(βTM)患者的血液学和生化评估:一项横断面研究。

Hematological and biochemical evaluation of β-thalassemia major (βTM) patients in Gaza Strip: A cross-sectional study.

作者信息

Ayyash Hani, Sirdah Mahmoud

机构信息

Department of Hematology, European Gaza Hospital, Khanyounis, Gaza Strip, Palestine.

Department of Biology, Faculty of Science, Al Azhar University-Gaza, P O Box 1277, Gaza, Palestine.

出版信息

Int J Health Sci (Qassim). 2018 Nov-Dec;12(6):18-24.

PMID:30534039
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6257880/
Abstract

OBJECTIVES

In Gaza Strip, Palestine, β-thalassemia is a major public health problem where more than 300 β-thalassemia major (βTM) patients are currently being managed at governmental hospitals. We set up to evaluate the hematological and biochemical aspects of our βTM patients at the Gaza European hospital and their correlation with iron overload.

METHODS

Our study included 65 transfusion-dependent βTM, as well as 37 apparently healthy subjects as control group. The hematological and biochemical evaluations included complete blood count, coagulation profile liver and kidney function tests, fasting blood sugar, lipid profile, and serum ferritin.

RESULTS

Deteriorated hematological and biochemical statuses were reported in both males and females of βTM patients as compared to the control group. Statistical comparisons showed no significant differences between males and females βTM patients in all parameters except for total cholesterol. The results concerning the splenectomized versus non-splenectomized patients revealed significantly higher values in splenectomized patients for white blood cell (WBC), platelet, aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, albumin, total protein, cholesterol, and potassium concentration compared to the non-splenectomized patients. Patients infected with hepatitis C virus and/or hepatitis B virus showed significant decrease in WBC count as compared to infection free patients, while for serum urea and creatinine, the virally infected βTM patients revealed significantly higher values compared to infection free patients.

CONCLUSION

This study justified the necessity for strengthening the efforts for regular evaluation and follow-up of the βTM patients which could be used to improve or modify the management protocols and thus ameliorating their deteriorated hematological and biochemical status.

摘要

目的

在巴勒斯坦加沙地带,β地中海贫血是一个重大的公共卫生问题,目前有300多名重型β地中海贫血(βTM)患者在政府医院接受治疗。我们着手评估加沙欧洲医院βTM患者的血液学和生化指标及其与铁过载的相关性。

方法

我们的研究纳入了65名依赖输血的βTM患者以及37名健康受试者作为对照组。血液学和生化评估包括全血细胞计数、凝血指标、肝肾功能检查、空腹血糖、血脂谱和血清铁蛋白。

结果

与对照组相比,βTM患者的男性和女性血液学和生化指标均有所恶化。统计比较显示,除总胆固醇外,βTM患者的男性和女性在所有参数上均无显著差异。脾切除患者与未脾切除患者的结果显示,脾切除患者的白细胞(WBC)、血小板、天冬氨酸转氨酶、丙氨酸转氨酶、碱性磷酸酶、白蛋白、总蛋白、胆固醇和钾浓度均显著高于未脾切除患者。与未感染患者相比,感染丙型肝炎病毒和/或乙型肝炎病毒的患者白细胞计数显著降低,而对于血清尿素和肌酐,病毒感染的βTM患者的数值显著高于未感染患者。

结论

本研究证明有必要加强对βTM患者进行定期评估和随访的工作,这可用于改进或调整管理方案,从而改善其恶化的血液学和生化指标。

相似文献

1
Hematological and biochemical evaluation of β-thalassemia major (βTM) patients in Gaza Strip: A cross-sectional study.加沙地带重型β地中海贫血(βTM)患者的血液学和生化评估:一项横断面研究。
Int J Health Sci (Qassim). 2018 Nov-Dec;12(6):18-24.
2
Clinical and hematological features among β-thalassemia major patients in Jazan region: A hospital-based study.吉赞地区重型β地中海贫血患者的临床和血液学特征:一项基于医院的研究。
J Family Med Prim Care. 2020 Jan 28;9(1):412-417. doi: 10.4103/jfmpc.jfmpc_1007_19. eCollection 2020 Jan.
3
The Relation between Serum Hepcidin, Ferritin, Hepcidin: Ferritin Ratio, Hydroxyurea and Splenectomy in Children with β-Thalassemia.β地中海贫血患儿血清铁调素、铁蛋白、铁调素:铁蛋白比值、羟基脲与脾切除术之间的关系
Open Access Maced J Med Sci. 2019 Aug 14;7(15):2434-2439. doi: 10.3889/oamjms.2019.636. eCollection 2019 Aug 15.
4
Health Status of Patients With β-Thalassemia in the West Bank: A Retrospective-Cohort Study.约旦河西岸β地中海贫血患者的健康状况:一项回顾性队列研究。
Front Med (Lausanne). 2021 Dec 20;8:788758. doi: 10.3389/fmed.2021.788758. eCollection 2021.
5
Effect of iron overload on renal functions and oxidative stress in beta thalassemia patients.铁过载对β地中海贫血患者肾功能及氧化应激的影响。
Saudi Med J. 2016 Nov;37(11):1239-1242. doi: 10.15537/smj.2016.11.16242.
6
Jadenu Substituting Exjade in Iron Overloaded β-Thalassemia Major (BTM) Patients: A Preliminary Report of the Effects on the Tolerability, Serum Ferritin Level, Liver Iron Concentration and Biochemical Profiles.Jadenu替代去铁斯若用于重度β地中海贫血(BTM)铁过载患者:对耐受性、血清铁蛋白水平、肝脏铁浓度及生化指标影响的初步报告
Mediterr J Hematol Infect Dis. 2018 Nov 1;10(1):e2018064. doi: 10.4084/MJHID.2018.064. eCollection 2018.
7
Hematological and biochemical status of Beta-thalassemia major patients in Bangladesh: A comparative analysis.孟加拉国重型β地中海贫血患者的血液学和生化状况:一项比较分析。
Int J Hematol Oncol Stem Cell Res. 2016 Jan 1;10(1):7-12.
8
Comparison of Two Alternative Procedures to Obtain Packed Red Blood Cells for β-Thalassemia Major Transfusion Therapy.比较两种获取用于β-地中海贫血输血治疗的浓缩红细胞的替代方法。
Biomolecules. 2021 Nov 4;11(11):1638. doi: 10.3390/biom11111638.
9
Therapeutic efficacy of different iron chelators in Egyptian children with Beta Thalassemia with iron overload.不同铁螯合剂对埃及铁过载β地中海贫血患儿的治疗效果。
Infect Disord Drug Targets. 2015;15(2):98-105. doi: 10.2174/1871526515666150724111721.
10
Pharmacokinetics of deferiprone in patients with β-thalassaemia: impact of splenectomy and iron status.地拉罗司在β-地中海贫血患者中的药代动力学:脾切除术和铁状态的影响。
Clin Pharmacokinet. 2011 Jan;50(1):41-50. doi: 10.2165/11536630-000000000-00000.

引用本文的文献

1
Serum lipid profile abnormalities among beta-thalassemia patients: a systematic review and meta-analysis.β-地中海贫血患者的血脂谱异常:系统评价和荟萃分析。
Lipids Health Dis. 2024 Nov 25;23(1):388. doi: 10.1186/s12944-024-02377-6.
2
Impact of met-haemoglobin and oxidative stress on endothelial function in patients with transfusion dependent β-thalassemia.依赖输血的β-地中海贫血患者中高铁血红蛋白和氧化应激对血管内皮功能的影响。
Sci Rep. 2024 Oct 25;14(1):25328. doi: 10.1038/s41598-024-74930-3.
3
A Compact Differential Dynamic Microscopy-based Device (cDDM): An Approach Tool for Early Detection of Hypercoagulable State in Transfusion-Dependent-β-Thalassemia Patients.一种紧凑型差分动态显微镜设备(cDDM):用于早期检测输血依赖型β-地中海贫血患者高凝状态的方法工具。
ACS Appl Bio Mater. 2024 Jul 15;7(7):4710-4724. doi: 10.1021/acsabm.4c00516. Epub 2024 Jun 26.
4
Serological and molecular detection of in ß. thalassemia patients.β地中海贫血患者中[具体内容缺失]的血清学和分子检测
J Parasit Dis. 2023 Dec;47(4):778-786. doi: 10.1007/s12639-023-01624-4. Epub 2023 Aug 15.
5
Activation of STAT and SMAD Signaling Induces Hepcidin Re-Expression as a Therapeutic Target for β-Thalassemia Patients.STAT和SMAD信号通路的激活诱导铁调素重新表达作为β地中海贫血患者的治疗靶点。
Biomedicines. 2022 Jan 17;10(1):189. doi: 10.3390/biomedicines10010189.
6
Health Status of Patients With β-Thalassemia in the West Bank: A Retrospective-Cohort Study.约旦河西岸β地中海贫血患者的健康状况:一项回顾性队列研究。
Front Med (Lausanne). 2021 Dec 20;8:788758. doi: 10.3389/fmed.2021.788758. eCollection 2021.
7
The effects of iron overload, insulin resistance and oxidative stress on metabolic disorders in patients with β- thalassemia major.铁过载、胰岛素抵抗和氧化应激对重型β地中海贫血患者代谢紊乱的影响。
J Diabetes Metab Disord. 2020 Jun 3;19(2):767-774. doi: 10.1007/s40200-020-00560-x. eCollection 2020 Dec.
8
Clinical and hematological features among β-thalassemia major patients in Jazan region: A hospital-based study.吉赞地区重型β地中海贫血患者的临床和血液学特征:一项基于医院的研究。
J Family Med Prim Care. 2020 Jan 28;9(1):412-417. doi: 10.4103/jfmpc.jfmpc_1007_19. eCollection 2020 Jan.

本文引用的文献

1
Clinical Classification, Screening and Diagnosis for Thalassemia.地中海贫血的临床分类、筛查与诊断
Hematol Oncol Clin North Am. 2018 Apr;32(2):193-211. doi: 10.1016/j.hoc.2017.11.006.
2
Molecular Basis and Genetic Modifiers of Thalassemia.地中海贫血的分子基础与遗传修饰因子
Hematol Oncol Clin North Am. 2018 Apr;32(2):177-191. doi: 10.1016/j.hoc.2017.11.003.
3
The Evolving Spectrum of the Epidemiology of Thalassemia.地中海贫血流行病学的演变范围
Hematol Oncol Clin North Am. 2018 Apr;32(2):165-175. doi: 10.1016/j.hoc.2017.11.008.
4
A paradigm shift on beta-thalassaemia treatment: How will we manage this old disease with new therapies?贝塔地中海贫血治疗的范式转变:我们将如何用新疗法来治疗这种古老的疾病?
Blood Rev. 2018 Jul;32(4):300-311. doi: 10.1016/j.blre.2018.02.001. Epub 2018 Feb 12.
5
What can we learn from ineffective erythropoiesis in thalassemia?我们能从地中海贫血无效造血中学到什么?
Blood Rev. 2018 Mar;32(2):130-143. doi: 10.1016/j.blre.2017.10.001. Epub 2017 Oct 3.
6
Thalassaemia.地中海贫血症。
Lancet. 2018 Jan 13;391(10116):155-167. doi: 10.1016/S0140-6736(17)31822-6. Epub 2017 Jul 31.
7
Molecular basis of β thalassemia and potential therapeutic targets.β地中海贫血的分子基础及潜在治疗靶点
Blood Cells Mol Dis. 2018 May;70:54-65. doi: 10.1016/j.bcmd.2017.06.001. Epub 2017 Jun 20.
8
The new era of chelation treatments: effectiveness and safety of 10 different regimens for controlling iron overloading in thalassaemia major.螯合治疗的新时代:10种不同方案控制重型地中海贫血铁过载的有效性和安全性
Br J Haematol. 2017 Sep;178(5):676-688. doi: 10.1111/bjh.14712. Epub 2017 Apr 25.
9
Genotype-Phenotype Correlations of β-Thalassemia Mutations in an Azerbaijani Population.阿塞拜疆人群中β地中海贫血突变的基因型-表型相关性
Turk J Haematol. 2017 Aug 2;34(3):258-263. doi: 10.4274/tjh.2016.0427. Epub 2017 Jan 25.
10
β-Thalassemia.β地中海贫血
Genet Med. 2017 Jun;19(6):609-619. doi: 10.1038/gim.2016.173. Epub 2016 Nov 3.